PCSK9 inhibitor Evolocumab alleviates atherosclerosis progression by suppressing endothelial cell injury via the ROS/MAPK pathway. - Ma M; Liu F; Yin X; Yue J; Duan Y; Tang J (General physiology and biophysics, 2026)